McKesson sets earnings range as Barclays targets McKesson stock at USD 1,000.00

Published on 10/05/2026 at 14:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 105.38 billion, up 7.70 percent year over year. McKesson stock costs EUR 804.90 after EUR 801.80 on October 5, 2026.

Extreme Nahaufnahme weißer Tabletten und Kapseln auf glänzender Metallfläche — Makroaufnahme unbeschrifteter Tabletten steht sinnbildlich für Produktsegment von McKesson Corporation ISIN US58155Q1031 im Detail, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) was trading at EUR 804.90 at Lang & Schwarz on October 5, 2026 at 2:09 p.m. CEST, while the company set a fiscal 2027 earnings range and Barclays targeted McKesson stock at USD 1,000.00. MarketBeat reported on October 1, 2026 that McKesson set adjusted earnings per share guidance at USD 44.20-45.00, while Barclays had lifted its target from USD 925.00 to USD 1,000.00 on August 19, 2026.

Guidance meets consensus

The fiscal 2027 guidance range centers on USD 44.60, only USD 0.05 below the USD 44.65 consensus cited by MarketBeat. That narrow gap makes execution against the outlook more important than a headline forecast surprise.

MarketBeat also reported that McKesson raised its quarterly dividend from USD 0.82 to USD 0.94 per share, creating an annualized payout of USD 3.76 and a yield of 0.40 percent.

Quarterly growth carries weight

In the fiscal first quarter of 2027, revenue reached USD 105.38 billion, up 7.70 percent from the year-earlier period. Adjusted earnings per share came to USD 9.93, compared with a USD 9.56 consensus estimate and USD 8.26 in the prior-year quarter, according to MarketBeat.

The operating profile is still dominated by scale. McKesson describes its business as a logistics and healthcare-services platform spanning pharmaceutical distribution, medical supplies, oncology and multispecialty solutions, and prescription technology services, according to McKesson.

Stock remains below yearly high

The primary exchange context was a last price of USD 902.28 on the NYSE on October 2, 2026 at 4:00 p.m. ET. The one-year range was USD 723.68 to USD 999.00, placing that primary-market price USD 96.72 below the high, while market capitalization stood at USD 105.6 billion.

For investors, the key comparison is the distance between the guidance midpoint and consensus: McKesson's USD 44.60 midpoint sits USD 0.05 below the USD 44.65 estimate, leaving the operating results and the November reporting date as the next measurable checkpoints. The company is scheduled to report fiscal second-quarter results after the market close on November 4, 2026, according to Quiver Quantitative.

Trading reference for October 5

McKesson was trading at EUR 804.90 at Lang & Schwarz on October 5, 2026 at 2:09 p.m. CEST, up 0.39 percent versus the prior close of EUR 801.80 at Lang & Schwarz on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.